Chairman of the People’s Labour Party (PLP) Douglas Wattley has resigned as Chairman of ZBC Board. In a post on his Facebook page on Sunday (July 3), Mr. Wattley wrote “Here is a bit of good news for some – on Friday 1st July 2016, I tendered my resignation as Chairperson of the ZBC Board of Directors.”
Mr. Wattley, who did not give any specific reason for his departure, joins former Press Secretary to PM Harris in leaving the Unity government in just 16 months of taking office in SKN. In recent months public disagreements over transparency, accountability and governance have surfaced among members of the PLP which is led by Prime Minister Dr Timothy Harris, and forms part of the PAM/CCM/PLP Unity administration.
Both Wattley and Phillip have taken the Team Unity Government to task saying that this is not what was promised by the TUG and have accused the government of rampant nepotism and corruption.
While at ZIZ Wattley endeavored to make the national government owned entity more democratic and responsive to the needs of ordinary citizens. Freedom Fm was unable to contact Mr. Wattley at news time on Wednesday.
However in a subsequent FB post ,Wattley who has taken the side of retired CMO Dr Patrick Martin in the ongoing Stem Cell scandal at the JNF General hospital, posted about the lack of professionalism, and not following the legal and ethical framework by the Ministry of Health and the TUG, which required approval and sanction from the CMO .
“Who was the doctor-in-charge? Lagrotta? Archibald? Wilkinson? Which of these is a specialist in regenerative-stem cell treatment? Asks Wattley.
Did the medical product come from the hospital pharmacy, a local private pharmacy, or from somewhere else inside or outside the Federation?The Infusion Protocol and Dr Redmond’s input tell that the product was Human Umbilical Cord Blood Plasma. It was brought into the Federation.Was there a Customs Declaration and licence/permission to import given by the Ministry of Health? The latter answer is No.
No import request made to the competent medicine authority – the Office of the CMO.So, an experimental medical product is smuggled into the Federation to be part of a Phase 2 clinical trial that had no ethics review as is required.The medical product was sneaked into the government’s hospital; given to patients whose admission to the Private Ward was by irregular means.
The patients were being attended to by an unregistered doctor; assisted by a hospital GP; supervised by a surgeon who is the Medical Chief of Staff; and who is now the Acting CMO; who is bound by duty to investigate all of the illegal and irregular acts.
Who and what should the Acting CMO investigate? “ asks Wattley